ORGO
Organogenesis Holdings Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.02
+2.03%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.05
From 52W high−84.40%
Volume996942.00
Market cap$131.25M
P/E (TTM)—
P/S (TTM)0.3x
Div yield—
Key dataOct 19, 2026
Open
$1.05
From 52W high
−84.40%
Volume
996942.00
Market cap
$131.25M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−161.4x
P/E (TTM)
—
RSI (14)
18.0
MomentumView details →
1D Return
+2.03%
YTD Return
−81.64%
SummaryUpdated Jun 1, 2026
Organogenesis Holdings Inc. (NASDAQ:ORGO) is a regenerative medicine company founded in 1985 and headquartered in Canton, Massachusetts. The company develops, manufactures, and commercializes advanced biological solutions primarily for wound care and surgical applications. Since going public in 2017, Organogenesis has established itself as a leading player in the regenerative medicine space, focusing on products that harness the body's natural healing processes to treat complex medical conditions.
Similar companies
Latest newsMore news →